PepGen Inc. , a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies, today announced that based on the levels of dystrophin protein measured in the 10 mg/kg ...

C3.ai, Inc. ("C3 AI," "C3," or the "Company") , the Enterprise AI application software company, today announced financial results for its fiscal fourth quarter and full fiscal year ended April 30, ...